NCT00036413
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
- Locations
-
- Neurological Institute New York, United States
Clinical trial condition
Proteostasis Deficiencies
Explore clinical trials studying Proteostasis Deficiencies. Study availability and eligibility vary by location and protocol.
1,350 public trials
353 recruiting studies
Proteostasis Deficiencies trial results
NCT00230074
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
- Locations
-
- Novartis East Hanover, New Jersey, United States
NCT00006362
- Conditions
- Amyloidosis, Blood Protein Disorders, Burkitt Lymphoma, +50 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
- University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States
NCT00416169
- Conditions
- Brain Diseases, Central Nervous System Diseases, Dementia, +11 more
- Locations
-
Not specified
NCT00661999
- Conditions
- Amyloidosis, Anemia, Blood Protein Disorders, +72 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic Rochester, Minnesota, United States
NCT00606918
- Conditions
- Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis & Other Neuromuscular Disorders, Central Nervous System Diseases, +13 more
- Locations
-
- Massachusetts General Hospital - East Charlestown, Massachusetts, United States
NCT00002504
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +84 more
- Locations
-
- Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
- Bloomington Hospital Bloomington, Indiana, United States
- St. Vincent Hospital and Health Care Center Research Department Indianapolis, Indiana, United States
- Bergan Mercy Medical Center Omaha, Nebraska, United States
NCT00621400
- Conditions
- Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +9 more
- Locations
-
- CHRU d'Amiens Amiens, France
- CHRU de Lille Lille, France
- CHU de Limoges Limoges, France
- CHU de Nantes Nantes, France
Completed
Efficacy of CC-5013 (Revlimid or Lenalidomide) in Patients With Primary Systemic Amyloidosis
NCT00166413
- Conditions
- Amyloidosis, Metabolic Diseases, Nutritional and Metabolic Diseases, +1 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
NCT00880347
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Arterial Occlusive Diseases, +31 more
- Locations
-
- Hôpital Privé Les Magnolias Ballainvilliers, France
- Cabinet Médical Bergerac, France
- Centre Médical Dijon, France
- Cabinet Médical La Seyne-sur-Mer, France